Publication type: | Article in scientific journal |
Type of review: | Peer review (publication) |
Title: | A novel 99mTc labelling strategy for the development of silica based particles for medical applications |
Authors: | Wuillemin, Michel A. Stuber, Wanda T. Fox, Thomas Reber, Michael J. Brühwiler, Dominik Alberto, Roger Braband, Henrik |
DOI: | 10.1039/C3DT53019A |
Published in: | Dalton Transactions |
Volume(Issue): | 43 |
Issue: | 11 |
Page(s): | 4260 |
Pages to: | 4263 |
Issue Date: | 2014 |
Publisher / Ed. Institution: | Royal Society of Chemistry |
ISSN: | 1477-9226 1477-9235 |
Language: | English |
Subjects: | Technetium; Mesoporous; Radioimaging; Silica |
Subject (DDC): | 540: Chemistry 610: Medicine and health |
Abstract: | The reaction of high-valent fac-{99mTcO3}+ complexes with alkenes ((3+2)-cycloaddition) has been used to develop a novel labelling procedure for silica based particles. This strategy can help to gain more detailed in vivo data of mesoporous silica by non-invasive radioimaging in the future. By applying norbornene as a coupling unit the (3+2)-cycloaddition reaction proceeds stereoselectively and with high reaction rates. |
URI: | https://digitalcollection.zhaw.ch/handle/11475/2607 |
Fulltext version: | Published version |
License (according to publishing contract): | Licence according to publishing contract |
Departement: | Life Sciences and Facility Management |
Organisational Unit: | Institute of Chemistry and Biotechnology (ICBT) |
Published as part of the ZHAW project: | Molecular Alignment Chips (MACs) |
Appears in collections: | Publikationen Life Sciences und Facility Management |
Files in This Item:
There are no files associated with this item.
Show full item record
Wuillemin, M. A., Stuber, W. T., Fox, T., Reber, M. J., Brühwiler, D., Alberto, R., & Braband, H. (2014). A novel 99mTc labelling strategy for the development of silica based particles for medical applications. Dalton Transactions, 43(11), 4260–4263. https://doi.org/10.1039/C3DT53019A
Wuillemin, M.A. et al. (2014) ‘A novel 99mTc labelling strategy for the development of silica based particles for medical applications’, Dalton Transactions, 43(11), pp. 4260–4263. Available at: https://doi.org/10.1039/C3DT53019A.
M. A. Wuillemin et al., “A novel 99mTc labelling strategy for the development of silica based particles for medical applications,” Dalton Transactions, vol. 43, no. 11, pp. 4260–4263, 2014, doi: 10.1039/C3DT53019A.
WUILLEMIN, Michel A., Wanda T. STUBER, Thomas FOX, Michael J. REBER, Dominik BRÜHWILER, Roger ALBERTO und Henrik BRABAND, 2014. A novel 99mTc labelling strategy for the development of silica based particles for medical applications. Dalton Transactions. 2014. Bd. 43, Nr. 11, S. 4260–4263. DOI 10.1039/C3DT53019A
Wuillemin, Michel A., Wanda T. Stuber, Thomas Fox, Michael J. Reber, Dominik Brühwiler, Roger Alberto, and Henrik Braband. 2014. “A Novel 99mTc Labelling Strategy for the Development of Silica Based Particles for Medical Applications.” Dalton Transactions 43 (11): 4260–63. https://doi.org/10.1039/C3DT53019A.
Wuillemin, Michel A., et al. “A Novel 99mTc Labelling Strategy for the Development of Silica Based Particles for Medical Applications.” Dalton Transactions, vol. 43, no. 11, 2014, pp. 4260–63, https://doi.org/10.1039/C3DT53019A.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.